Quantum BioPharma Ltd. is trading 14.2% down at $5.88 as investors extend a heavy sell-off following the company's Q1 2026 liquidity and business update.
- The stock has plummeted approximately 33% from its May 22, 2026, level of $9.24.
- Recent Q1 commentary highlighted significant concerns regarding the company's pre-revenue status, limited cash runway, and immediate financing requirements.
- Today's price action reflects a continuation of negative sentiment from last week rather than a response to a new company-specific announcement.